Mechanistic Insights of Rutin against Metabolic Disorders

Authors: Gupta K* and Murti Y

DOI: 10.23880/oajpr-16000281

Volume 7, Issue 2

Abstract

Rutin, a quercetin glycoside comes under the class flavonol. The aglycone part of rutin is known as quercetin. It is found in numerous fruits and plants, especially apricots, buckwheat, cherries, grapefruit, grapes, oranges, and plums. Rutin shows cardioprotective, neuroprotective, and nephroprotective effects mediated via its antioxidant mechanism. The neuroprotective effect of rutin is utilized in the treatment of Parkinson’s disease. It has been documented in the scientific literature that rutin improves obesity through brown fat activation, modulates DNA damage signaling in cancer cells, reduces inflammation by inhibiting eicosanoid biosynthesis, lipoxygenase, cyclooxygenase, and phospholipase A2 activities, enhances insulin release as well as decreases the expression of resistin along with increases the expression of PPAR γ in diabetic patients, increases total cholesterol, high-density lipoprotein and very low-density lipoprotein levels, whereas low-density lipoprotein level decreases resulting into antilipidemic activity, inhibits diabetic liver injury and diabetic cardiomyopathy. Repurposing of rutin was also done against SARS-CoV-2. Our study aims to survey the most recent progress with emphasis on how rutin adapts intracellular signaling cascades to treat different metabolic disorders. However, the precise cellular and molecular mechanisms of rutin are known and more clinical studies are required to provide a novel therapeutic approach for the treatment of metabolic disorders.

Keywords: Rutin; Flavonol; Metabolic Disorders; Cancer; Neuroprotective; Cardioprotective

View PDF